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Epigenetic alterations in cell-type-specific gene expression control the transition of neural stem cells (NSCs) from predominantly neurogenic to
predominantly gliogenic phases of differentiation, but how this switch occurs is unclear. Here, we show that brahma-related gene 1 (Brg1), an ATP-
dependent chromatin remodeling factor, is required for the repression of neuronal commitment and the maintenance of NSCs in a state that permits
them to respond to gliogenic signals. Loss of Brg1 in NSCs in conditional brg1 mutant mice results in precocious neuronal differentiation, such that
cells in the ventricular zone differentiate into post-mitotic neurons before the onset of gliogenesis. As a result, there is a dramatic failure of astrocyte
and oligodendrocyte differentiation in these animals. The ablation of brg1 in gliogenic progenitors in vitro also prevents growth-factor-induced
astrocyte differentiation. Furthermore, proteins implicated in the maintenance of stem cells, including Sox1, Pax6 and Musashi-1, are dramatically
reduced in the ventricular zones of brg1 mutant mice. We conclude that Brg1 is required to repress neuronal differentiation in NSCs as a means of
permitting glial cell differentiation in response to gliogenic signals, suggesting that Brg1 regulates the switch from neurogenesis to gliogenesis.
D 2005 Elsevier Inc. All rights reserved.Keywords: Neural stem cells; Brg1; Chromatin remodeling; Astrocytes; Neurons; OligodendrocytesIntroduction
The major cell types comprising the mammalian central
nervous system (CNS) arise from neural stem cells (NSCs),
including neuroepithelial cells that transition into multi-potent
radial glia, which initially reside in the ventricular zone (VZ) of
the developing brain and spinal cord (Sauvageot and Stiles,
2002). Neurons, astrocytes and oligodendrocytes differentiate
sequentially from NSCs, with most neurons being generated
before glial cells. This pattern of differentiation is recapitulated
in vitro, such that NSCs derived from early embryos (e.g.,
mouse embryonic day (E) 10–11) give rise exclusively to
neurons after short-term culture, while cortical progenitors
isolated after E13–14 become predominantly astrocytes under
the same culture conditions (Qian et al., 2000). Furthermore,0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2005.10.044
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E-mail address: shermanl@ohsu.edu (L.S. Sherman).NSCs derived from early embryos switch from being predom-
inantly neurogenic to predominantly gliogenic over time in
vitro, suggesting that intrinsic changes in NSCs can regulate
neuronal versus glial differentiation (Sun et al., 2003).
Epigenetic modifications to cell-type-specific genes con-
tribute to the cell autonomous changes in NSCs that regulate
neurogenic and gliogenic differentiation. The selective expres-
sion of transcription factors accompanied by chromatin
remodeling, DNA methylation and localization of chromatin
to specialized nuclear domains have all been implicated in
regulating NSC fate determination (Hsieh and Gage, 2004;
Cheng et al., 2005). Such alterations in cell-type-specific genes
allow differentiated cells to maintain their identity even when
confronted with extracellular cues that drive the differentiation
of other cell types and are also required for NSC maintenance,
ensuring that the needed numbers of cells are present to
differentiate into neurons and glia at appropriate times during
development. The signals that trigger these epigenetic changes
are not well defined.89 (2006) 372 – 383
www.e
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chromatin remodeling protein complexes, called brahma-
related gene-1 (Brg1), is a key mediator that regulates
neurogenesis versus gliogenesis. SWI/SNF chromatin remodel-
ing complexes utilize energy from ATP hydrolysis to disrupt
histone–DNA interactions, resulting in transcriptional activa-
tion or repression (Martens and Winston, 2003). Mammalian
SWI/SNF complexes contain one of two catalytic ATPase
subunits: Brm (for Brahma; also called SNF2a) and Brg1 (also
called SNF2h). During mouse organogenesis, Brg1 transcripts
are expressed in post-mitotic neurons and other cells in the
mantle zone of the spinal cord and the intermediate and cortical
layers of the forebrain in E12 mice, but less so in proliferating
neurogenic NSCs in the VZ (Randazzo et al., 1994). By E15,
there are increased levels of Brg1 transcripts in the predomi-
nantly gliogenic NSCs of the VZ and, later, in the subven-
tricular zone (SVZ). Brg1 may therefore play a role in nervous
system development. In support of this notion, zebrafish with
brg1 mutations have defects in terminal differentiation of
retinal ganglion cells (Link et al., 2000; Gregg et al., 2003).
Furthermore, in Xenopus, Brg1 is required for neuronal
differentiation by mediating the transcriptional activities of
the proneural bHLH proteins neurogenin-related-1 and NeuroD
(Seo et al., 2005). Given that Brg1 is not expressed by
predominantly neurogenic NSCs during early mouse develop-
ment but is expressed later throughout the VZ during
gliogenesis, we postulated that Brg1 signals the transition from
neurogenesis to gliogenesis during mammalian development.
Materials and methods
Mice
Male nestin-cre mice were generously provided by Akira Imamoto,
University of Chicago (Tronche et al., 1999) and were mated with female
brg1FL/FL mice between 3 and 6 months of age. Animals were genotyped as
previously described (Sumi-Ichinose et al., 1997).
Immunohistochemistry
Embryos were harvested, and CNS tissues were dissected and immersion-
fixed at 4-C overnight, extensively washed in PBS and equilibrated in 30%
sucrose. The tissue was embedded in freezing medium (TBS, Triangle Biomed.
Sci.) and sectioned at 20 Am on a cryostat (Hacker Inst.). Sections were labeled
with primary antibodies and detected with fluorescence-labeled secondary
antibodies as previously described Liu (Strobeck et al., 2001; Potten et al.,
2003; Liu et al., 2004a,b). Antibodies were obtained from the following
sources: anti-Brg1 (Santa Cruz), HuC/D (Molecular Probes), cleaved-caspase-3
(Cell Signaling), GFAP (Dako), CD44 (ATCC), vimentin (Biomeda), RC2
(DSHB), Cre (Covance), PDGFRa (BD Pharmingen), Nkx2.2 (DSHB), Sox1
(DSHB), olig2 (kind gift of D. Rowitch), MBP (Chemicon), PLP (Chemicon),
Ki67 (Novocastra), h-III tubulin (Covance), NeuN (Chemicon), S100h (Sigma)
and Pax6 (DSHB). Anti-musashi-1 was a gift from Dr. H. Okano. DAPI was
used at 1:5000 (Molecular Probes). TUNEL assays were performed using a
DNA Fragmentation Assay kit (Clontech).
Cell culture
Cerebral cortices or GE were dissected from E12–14 Brg1FL/FL embryos.
Tissue was incubated in trypsin–EDTA at 37-C for 10 min, washed and gently
dissociated by trituration through a 25 g needle. Dissociated cells were grown for1–5 days as ‘‘neurospheres’’ in a non-differentiating medium consisting of F12/
DMEM (1:1; Gibco) supplemented with 0.1% BSA, B27, N2, FGF2 (a gift from
F. Eckenstein; 10 ng/ml) and EGF (Upstate Biotech.; 10 ng/ml) and antibiotics.
Neurospheres were dissociated and plated onto glass coverslips coatedwith poly-
l-lysine and laminin (Sigma). Cultures were infected with 3.6  107 pfu of
adeno-cre or adeno-EGFP (Gene Transfer Vector Core Facility, University of
Iowa). Forty-eight hours after infection, some cultures were treated with CNTF (a
gift from R. Nishi; 10 ng/ml) to induce astrocyte differentiation.
DNA microarrays
Total RNA from cortical and spinal tissues was isolated using TRIzol\
(Invitrogen) following the manufacturer’s instructions. Non-radioactive GEAr-
ray Q series cDNA expression array filters (Cat nos.: MM-0002, apoptosis;
MM-001, cell cycle; MM-601.2, stem cells; SuperArray Inc.) were used to
perform focused array analysis as described previously (Luo et al., 2005).
Results
Brg1 expression is upregulated in the mouse VZ after E13
Consistent with the localization of brg1 transcripts (Ran-
dazzo et al., 1994), Brg1 protein was undetectable by
immunohistochemistry in E13 and earlier mouse cortical and
spinal cord VZ (Figs. 1a–e). Brg1 immunoreactivity was,
however, detected throughout the cephalic neural tube and
developing spinal cord by cells expressing the pan-neuronal
marker, HuC/D, suggesting that neurons express Brg1 as they
differentiate. Floor plate cells in the ventral spinal cord were
also weakly positive for Brg1 (Fig. 1d, arrowhead). This
pattern of Brg1 expression changes between E14 and birth,
such that the majority of cells in the VZ as well as in the
cortical and spinal cord gray matter become Brg1-immunore-
active (Figs. 1f–i). This change in Brg1 expression correlates
with the transition of the cortical VZ from producing
predominantly neuronal to predominantly glial cell progenitors.
We therefore further investigated the role of Brg1 in producing
these neural lineages.
Loss of Brg1 in the developing CNS causes severe cortical
malformation
Because brg1-null mice die before implantation (Bultman et
al., 2000), we tested the role of Brg1 in the developing murine
CNS by crossing mice in which the brg1 gene contains loxP
sites in the intron upstream of exon 2 and in the intron
downstream of exon 3 (Sumi-Ichinose et al., 1997) with mice
expressing cre recombinase under the control of the nestin
promoter (Tronche et al., 1999). The presence of cre and the
deletion of brg1 in nestin-cre (NC)-Brg1FL/FL mice were
verified by PCR analysis of DNA from the brains of mutant
as compared to wild type animals (Fig. 2a). By immunohisto-
chemical analysis, NC-Brg1FL/FL mice lacked Brg1 protein in
most regions of the CNS (Fig. 2b) and PNS (not shown). NC-
Brg1FL/FL embryos developed at Mendelian ratios up to birth
but died shortly thereafter, failing to inflate their lungs.
Although the fetuses appeared grossly normal, brains from
these mutant mice had severely malformed cerebral and
cerebellar cortices, while the midbrain and brainstem appeared
Fig. 1. Brg1 expression is induced in NSCs in the VZ after E13. Immunostaining for Brg1 (black; a, c, d, f, g, h) and HuC/D (red; b, e, i) in E13 (a–e) and E14 (f– i)
cortex a, b, f and spinal cord c–e and g– i. Arrows in panel a indicate Brg1-labeled cells. Arrows in panels a, c and d indicate Brg1-labeled cells; arrowhead in panel
d indicates floor plate cells in the developing spinal cord.
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outside of the CNS appeared normal (data not shown). A
histological evaluation of the brains of E19 and older NC-
Brg1FL/FL mice indicated that cerebral cortical organization was
abnormal. In the oldest mutant mice examined (shortly after
birth), we detected an extensive reduction in cell number and
abnormal cytoarchitecture in the cerebral cortex (Figs. 2e–i and
see below).
Early mouse neuronal differentiation does not depend on Brg1
To assess which specific cell types are affected by loss of
Brg1, we labeled brain and spinal cord tissues from NC-Brg1FL/FL embryos with cell-type-specific markers. A screen
with pan-neuronal markers indicated that neuronal differentia-
tion proceeds apparently unabated at early stages (up to E13) in
the cortex (Figs. 3a, b) and spinal cord (not shown) of NC-
Brg1FL/FL mice. An examination of neuronal subtype-specific
markers in brg1 mutant mice indicated that the earliest generated
cortical neurons, the Cajal–Retzius (CR) cells, begin to
differentiate at their normal time (E10.5) and that they migrate,
as expected, to the marginal zone where they form a plexus
covering the cortical surface (Figs. 3c–h). These observations of
early, outwardly normal neuronal differentiation in the absence
of Brg1 are consistent with our finding that Brg1 is not
detectable in the VZ during this stage of development.
Fig. 2. Aberrant cortical development in the absence of Brg1. (a) PCR genotyping of embryos from female wild type and Brg1FL/FL mice mated with male nestin-cre
(NC) mice. DNA from wild type mice served as a negative control. (b) Sections of E15.5 cerebral cortex labeled with an anti-Brg1 antibody verifying the loss of
Brg1 expression in NC-brg1FL/FL mice. (c) Whole brain from a neonatal NC-brg1FL/FL mouse and (d) a wild type littermate. Both brains were imaged at the same
magnification. (e, g) Hematoxylin and eosin-stained paraffin sections of neonatal NC-brg1FL/FL and (f, h, i) wild type littermate cerebral cortex. Note the reductions
in cortical thickness and cell density in the mutant.
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become committed to neuronal lineages
Although the brg1 mutant CR neurons display an outwardly
normal pattern of differentiation at early stages, there are two
potentially revealing anomalies that become evident once
neurons begin to express early neuronal markers (e.g., HuC/
D). First, CR neurons form an abnormally thick layer of cells in
the mutant cortex (compare Figs. 3c and d). This may be theresult of a relatively normal complement of cells populating the
progressively reduced surface area of the mutant cortex. Second,
there is evidence that the CR cells are maturing precociously.We
observe, for example, calretinin+/reelin+ cells in the ventricular
and developing intermediate zones of the brg1 mutant embryos
(compare Figs. 3e, f and g, h). These cells appear to be CR cells
in the process of migrating to the cortical surface. Control CR
cells do not normally display calretinin or reelin immunoreac-
tivity until after they have completed migration (e.g., Figs. 3e, f).
Fig. 3. Premature loss of the VZ in NC-brg1FL/FL mice. (a, b) Sections from E13 cerebral cortex of wild type (+/+; a) and NC-brg1FL/FL (/; b) mice labeled with
DAPI (blue) or HuC/D (red). Note that neurogenesis, including cortical plate development (arrows), appears essentially normal in the mutant cortex. (c, d) Calretinin
immunolabeling of cortical sections from E12 wild type (c) and NC-brg1FL/FL (d) mice. Note that CR neurons form at the normal time and migrate to the marginal
zone (arrows), but they express calretinin before migrating from the VZ (d, arrowheads). (e–h) Calretinin (green) and reelin (red) immunolabeling in cortical sections
from E14 mice. Calretinin+/reelin (i.e. not CR neurons; arrowheads) cells are located in the developing intermediate zone of mutant mice.
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evident after E14, when there are abnormalities in cortical
layering and pyramidal neuron morphology in the NC-
Brg1FL/FL mutants (e.g., compare Figs. 4a and b). Further-
more, after E14, nearly all of the cells in the VZ appear to be
post-mitotic neurons as they are Ki67 and HuC/D+
(compare Figs. 4c and d, and e and f). At the oldest stages
examined (between E18 and immediately following birth),
we observed a dramatic loss of neurons in the cortex (e.g.,
Fig. 4b). This loss is likely due, in part, to a deficiency in
trophic support as a result of the loss of glia (see below).
However, given that the VZ becomes filled with post-mitotic
HuC/D+ cells by E14, it is likely that many neuronal
progenitors are also exhausted before E14, resulting in the
failure of later neuronal populations to differentiate in the
absence of Brg1 (see below).
Cortical neurons derived from subcortical proliferative
zones are also affected by the absence of Brg1. Many cortical
interneurons, for example, migrate along a tangential pathway
into the cortex from their origins in the ganglionic eminences
(Lavdas et al., 1999). Normally, the location of these cells
during their migration cannot be determined without exper-
imental intervention (injecting a dye or forcing the expression
of a marker). In the NC-Brg1FL/FL mutant cortex, however,
large numbers of calretinin+ cells are observed throughout the
migratory pathway of these interneurons (compare Figs. 4g
and h). These calretinin+ neurons can be distinguished from
the CR cells because they are not reelin+ (e.g., Figs. 3g, h).
At later stages, the organization of the calretinin+ neurons inthe deeper cortical layers is grossly abnormal in the mutants,
including a failure to form the subplate at E15 (not shown).
These data suggest that Brg1 regulates neuronal maturation
but that, unlike in lower vertebrates (Seo et al., 2005), it is
not necessary for the initiation of neuronal differentiation in
mammals. To test if Brg1 regulates neuronal maturation, we
cultured neurogenic NSCs from E12 ganglionic eminences
(GE) of Brg1FL/FL mice. Brg1 expression was abolished by
infecting the cultures with an adenovirus carrying a cre
recombinase expression vector (adeno-cre; Figs. 4i–k).
Controls were infected with an adenovirus containing an
enhanced green fluorescent (adeno-EGFP) expression vector.
Typically, >90% of the cells were infected by the adenovirus
(e.g., Figs. 4i, j). Adeno-cre-infected NSCs lost Brg1
expression within 48 h post-infection (Fig. 4k). Loss of
Brg1 from GE-NSCs caused a rapid (within 24 h of viral
infection) increase in the numbers of cells expressing
calretinin (in one experiment, the percentage of calretinin+
cells increased from 0.8% in control cultures to 17% in
adeno-cre-treated cultures without a significant change in total
cell number; see Figs. 4l, m). These cells became post-mitotic
as indicated by loss of Ki67 labeling and a lack of BrdU
incorporation (data not shown). These data suggest that Brg1
regulates neuronal differentiation.
Most macroglia fail to differentiate in brg1 mutant mice
The loss of Brg1 had profound effects on gliogenesis. The
NC-Brg1FL/FL mice displayed a dramatic reduction in the
Fig. 4. Premature maturation of cortical neurons in NC-brg1FL/FL mice. (a, b) HuC/D labeling of cortical sections from wild type (a) and mutant (b) cortex at E18.
Note that, in the absence of Brg1, both cytoarchitecture and neuronal morphology are aberrant. In particular, cells with the morphologies of pyramidal neurons do
not appear to be present in the mutants. (c, d) Ki-67 labeling in the VZ of E14 wild type (c) and mutant (d) mice. By this stage, nearly all of the cells in the VZ
appear to be post-mitotic in NC-brg1FL/FL mice. (e, f) HuC/D and DAPI labeling of wild type (e) and mutant (f) cortex at E14. In wild type mice, there is a clear
VZ that lacks HuC/D immunoreactivity (arrow). In NC-brg1FL/FL mice, however, the area where the VZ should be is comprised of HuC/D+ cells. (g, h) Calretinin
immunolabeling in the GE of wild type (g) and mutant (h) mice. Note the extensive calretinin labeling in the GE of mutant mice (h, arrow). (i –k) Cultures of NSCs
derived from an E12 Brg1FL/FL mouse and infected with an adenovirus carrying a cre recombinase expression vector (adeno-cre). Infection efficiency was >90% as
demonstrated in panel j where virtually all DAPI-positive cells (i) express cre and show no Brg1 immunoreactivity (k). (l, m) Calretinin (red) and DAPI (blue)
labeling in GE-NSCs cultured from E12 Brg1FL/FL mice and infected with a control adenovirus or adeno-cre. Note that, in the absence of Brg1, NSCs express
calretinin (m).
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astrocyte progenitors, and GFAP, a marker of mature
astrocytes, in the brains and spinal cords of brg1 mutant
mice (Figs. 5a–h) between E14 and E18. This finding
suggests that cells in the astrocyte lineage were absent from
most regions of the CNS in these animals. Consistent with
this idea, cortical sections from brg1 mutant mice displayed
extensive HuC/D immunoreactivity in areas of presumptive
white matter (e.g., Fig. 4f) and, when stained with hematox-ylin and eosin, very few cells with astrocyte-like morpholo-
gies (data not shown). The proportion of cells in the mutant
cortex and spinal cord that expressed oligodendrocyte
progenitor markers (olig2, nkx2.2, PDGFRa) as well as
myelin protein markers (PLP and MBP) was also dramatically
reduced between E14 and E17 (Figs. 5i, j and data not
shown). These findings are consistent with the idea that Brg1
is required for the differentiation and/or maturation of
astrocytes and oligodendrocytes.
Fig. 6. Loss of Brg1 directly inhibits astrocyte differentiation by gliogenic NSCs
in vitro. (a–c) Cultures of cortical NSCs derived from E14 NC-brg1FL/FL mice
infected with adeno-cre (right panels) or a control adenovirus (left panels) and
labeled with either an anti-GFAP (a, b) or an anti-vimentin (c, d) antibody. Cells
were treated with CNTF (10 ng/ml) following infection to promote astrocyte
differentiation. Note the presence of GFAP-immunoreactive cells with astrocyte
morphology in the control cultures but only radial glial-like cells in the adeno
cre-infected cultures. Insets in panels a and b show that Brg1 immunoreactivity is
ubiquitous in control cultures and virtually absent from adeno-cre-infected
cultures.
Fig. 5. Reduced glial cell differentiation in the absence of Brg1. (a, b) Frontal
sections of cerebral cortex from an E18.5 NC-Brg1FL/FL mouse (a) and wild
type littermate (b), showing a dramatic loss of GFAP immunoreactivity in the
mutant brain, with the exception of limited subcortical areas (e.g., arrow). (c– j)
Spinal sections from E14 mutant (left panels) and wild type (right panels) mice
labeled with antibodies against astrocyte markers, including CD44 (c, d; an
early marker of astrocyte differentiation (Liu et al., 2004a,b)), GFAP (e, f) and
S100h (g, h) as well as the early oligodendrocyte marker olig2 (i, j). Note that
all markers of glial progenitor cells are dramatically reduced in NC-brg1FL/FL
mice.
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To determine if Brg1 directly influenced gliogenesis, we
examined the ability of gliogenic cortical NSCs harvested at
E14 to differentiate into astrocytes in the presence or absence
of Brg1. Cortical NSCs from E14 Brg1FL/FL mice were placed
into cell culture and infected with either adeno-cre or adeno-
EGFP as above. The cultures were induced to differentiate
into astrocytes by adding ciliary neurotrophic factor (CNTF).If CNTF was added 48 h after infection with adeno-cre (when
Brg1 expression was ablated; Figs. 6a, b insets), GFAP-
labeled cells with astrocyte-like morphologies were not
detected (compare Figs. 6a and b). Instead, all of the GFAP+
cells in these cultures had very long, unbranched processes
that were also vimentin+, suggesting that they were radial
glial cells (Figs. 6c, d). We did not observe any differences in
the levels of cell death in control as compared to adeno-cre-
infected cultures as assessed by TUNEL labeling and
immunostaining with an anti-cleaved caspase-3 antibody,
and Brg1 did not influence BrdU incorporation (data not
shown). If adeno-cre was added at the same time as CNTF or
later, numerous GFAP+ cells with astrocyte-like morphologies
arose in these cultures (not shown), suggesting that Brg1 is
not required for astrocyte survival once astrocyte differenti-
ation has been induced.
Brg1 is required to maintain gliogenic populations of NSCs
We conclude from these studies that Brg1 is not required
for neuronal differentiation but is required for aspects of
neuronal maturation and for the differentiation of gliogenic
NSCs into astrocytes and at least some oligodendrocytes.
Reduced numbers of glial cells in NC-Brg1FL/FL mice may
result from the depletion of NSCs from the VZ during the
neurogenic period. In support of this hypothesis, we observed
a decrease in radial glia during the neurogenic to gliogenic
transition in brg1 mutant animals. Vimentin+/RC2+ radial glia
were present in the Brg1 mutant mice but in reduced numbers
when examined in brains and spinal cords at E14 and E17-
Table 1
Altered expression of NSC-related transcripts in Brg1 mutant mice
Genebank Symbol Gene name Fold change
over wt
NM_008634 MAP1B Microtubule-associated
protein 1B
1.3
Y00051 NCAM1 Neural Cell Adhesion
Molecule 1
0.4
U46155 Ptch Patched (Drosophila)
homolog
0.3
NM_009819 Catna2 Catenin alpha 2 0.3
M27130 CD44 CD44 glycoprotein 0.01
NM_009233 Sox1 SRY-box containing gene 1 0.1
AJ010604 Sox5 SRY-box containing gene 5 1.3
NM_013627 Pax6 Paired box gene 6 4.8
NM_008809 Pdgfrb PDGF receptor, beta 16.8
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generally altered in the Brg1 mutant mice, we analyzed the
expression of a large number of stem-cell-related genes by
DNA microarray analysis. A small number of stem-cell-
related genes were expressed at lower levels in Brg1 mutant
mice at E14 as compared to wild type animals (Table 1).
Antibody screens for the expression of some of these markers
confirmed that NSC numbers were dramatically reduced in
the brains and spinal cords of Brg1 mutant mice, including
Sox1 (Figs. 7g–j) and Pax6 (Figs. 7k–n).
These data suggest that Brg1 is required to maintain the
expression of at least some NSC-related genes or, possibly, for
the maintenance of NSCs themselves. We tested this idea
further by labeling sections of wild type and NC-Brg1FL/FL
cortical sections at E10, E11, E14 and E17 for Musashi-1, an
RNA-binding factor that inhibits NSC differentiation (Kaneko
et al., 2000; Okano et al., 2002; Sakakibara et al., 2002). We
could not detect any differences in Musashi-1 immunoreactiv-
ity up to E11 (Figs. 8a, b). However, Musashi-1 was
significantly reduced in brg1 mutant cerebral cortex by E14
(Figs. 8c–h) and virtually absent by E17 (Figs. 8i–n).
As discussed above, the VZ appeared to be absent or
severely reduced in size throughout the CNS in NC-Brg1FL/FLFig. 7. Loss of Brg1 results in reduced numbers of NSCs in the VZ of mice during
spinal cord (b, c, e, f) of NC-brg1FL/FL mice at E14 (a–d) and throughout spinal tis
spinal cord VZ from wild type and brg1 mutant mice. (k–n) Pax6 expression in E14
brg1 mutant mice.mice by E14. Ventricular layers in the NC-Brg1FL/FL brain
were populated with cells expressing neuronal markers,
including HuC/D (e.g., Fig. 3h) and beta-III tubulin (not
shown). The area surrounding the central canal of the spinal
cord was similarly filled with cells expressing markers
expressed by post-mitotic neurons in brg1 mutant mice (Fig.
9). These data, along with the reduction of NSC markers
described above, support the hypothesis that the loss of Brg1gliogenesis. (a– f) RC2+ radial glia are reduced in the VZ of cortex (a, d) and
sues by E17 (e, f). (g– i) Sox1 expression in E14 dorsal (g, i) and ventral (h, j)
ventral (k, m) spinal cord VZ and adjacent mantle zone (l, n) from wild type and
Fig. 8. Musashi-1 expression is dramatically reduced in NC-brg1FL/FL NSCs. Expression of Musashi-1 (a, b, e, h, k and n; red) in sections from E11 (a, b). E14 (c–h)
and E17 (i–n) wild type and brg1 mutant mice double labeled with DAPI (blue). Panels in d, e, g, h, j, k and m, n are enlargements of the boxed areas to the left.
Note that musashi-1 expression appears to be unaltered at E11 but is dramatically decreased after E14.
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differentiate into astrocytes and oligodendrocytes. This effect
could be linked to altered cell cycle progression, leading to
premature neuronal differentiation, apoptosis of gliogenic
progenitors or both. Indeed, interactions between Brg1 and
the retinoblastoma tumor suppressor (pRB) can regulate cell
cycle progression by repressing targets of the E2F transcription
factor family, including cyclin E, cyclin A and CDC2 (Dunaief
et al., 1994; Strober et al., 1996; Trouche et al., 1997; Strobeck
et al., 2000; Zhang et al., 2000) and loss of Brg1 in other cell
types can result in E2F-mediated hyperproliferation (Dahiya et
al., 2000) or apoptosis (Liu et al., 2004a,b). We tested whether
Brg1 influenced the expression of genes that regulate cell cycle
progression using a targeted DNA microarray. By E14, the
levels of numerous cell cycle gene transcripts were altered in apattern consistent with cell cycle arrest (Table 2). In agreement
with these data, Ki67 (Figs. 4c, d) and PCNA (not shown),
markers for proliferating cells, were severely reduced in the
pallial VZ of E13.5 and older cortices but not at earlier stages.
A sample count of Ki67-labeled nuclei in the cortical ventricle
zone indicates very few proliferating cells at E14 (4 T 3%)
versus controls (57 T 18%).
Loss of proliferating cells in the VZ could be the result of
NSCs undergoing apoptosis or differentiating into post-mitotic
cells. Although we did not observe a significant increase in
pro-apoptotic gene expression at E14 in Brg1 mutant brains
(Table 3), we did observe increased labeling of the pro-
apoptotic marker cleaved caspase-3 in some VZ cells begin-
ning at E13 (Figs. 10a–e). These cells did not express RC2,
indicating that the predominant gliogenic NSC population was
Fig. 9. Aberrant expression of neuronal markers in brg1 mutant spinal cord.
Spinal cord sections from E14 brg1 mutant mouse spinal cords, showing NeuN
(top panel) and h-III tubulin (bottom panel) staining in the VZ (arrows).
Table 3
Altered expression of apoptosis-related transcripts in Brg1 mutant mice
Genebank Symbol Gene name Fold change
over wt
U19522 casp3 caspase 3 0.5
AJ224738 Cradd Death adaptor molecule 0.5
NM_009811 casp6 caspase 6 0.4
AF027707 Bok/mtd Bcl-2-related ovarian
killer protein
0.4
D83698 Bid3 BH3 interacting
(with BCL2 family)
0.2
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neuronal morphologies (e.g., Figs. 10f–i), and many of these
cells co-labeled with HuC/D (data not shown), indicating that
they were differentiated neurons. These findings are consistent
with our in vitro data, where we did not observe altered levels
of cell death in cells lacking Brg1. Apoptosis alone cannot,
therefore, explain the failure of Brg1-null NSCs to undergo
gliogenesis. It is possible that the few cells undergoing
apoptosis are dying due to lack of trophic signals.
Discussion
Our data indicate that Brg1 is a critical regulator of NSC
differentiation. Brg1 represses neuronal commitment in NSCs
prior to the onset of gliogenesis, permitting NSCs to remain
undifferentiated until they respond to gliogenic signals. This
function of Brg1 is distinct from its role in lower vertebrates. In
Xenopus, for example, virtually all neuronal differentiation was
blocked by inhibiting the expression of Brg1 or by blocking its
function (Seo et al., 2005). In zebrafish, the effect of ablating
brg1 was restricted to a loss of retinal ganglion cells (Gregg etTable 2
Altered expression of cell cycle-related transcripts in Brg1 mutant mice
Genebank Symbol Gene name Fold change
over wt
U36475 Brca1 Breast cancer 1 0.3
AF132483 cdk6 cyclin-dependent kinase 6 2.0
AF287135 Ccnh Cyclin H 2.4
X58708 Ccnb1-rs1 Cyclin B 2.5
AF016583 Chek1 Checkpoint kinase Chk1 3.0
Z47766 Ccnf Cyclin F 4.5
L76150 Cdkn2a p16 5.5
AF032131 E2F-6 E2F-like transcriptional
repressor
5.6
M64403 Ccnd1 Cyclin D1 5.8
U62638 Ccnc Cyclin C 6.0al., 2003). In Xenopus, the loss of Brg1 appears to cause a
failure of cell cycle arrest and an expansion of NSCs. Here, we
demonstrate a completely different role for Brg1 in mammalian
neural development. A targeted deletion of brg1 in mouse NSCs
leaves the early generation of neurons intact, while theFig. 10. Increased expression of cleaved caspase-3 in the cortical VZ of NC-
brg1FL/FL mice. (a–e) Sections from E13 wild type (+/+) and brg1 mutant
(/) mice labeled with RC2 (red) or cleaved caspase-3 (CC3; green). As
seen in the merged image (e), RC2+ radial glia (e.g., arrowheads) are not
immunolabeled with CC3 (e.g., arrows). Given that the majority of the CC3+
cells have large cell bodies and that nearly all of the cells in VZ are HuC/D+
in the mutant mice, the few cells that are undergoing apoptosis are likely to
be post-mitotic neurons. (f – i) DAPI (blue) and CC3 (green) labeling in E15
wild type and brg1 mutant mice. Note that there are still some dying cells
with neuronal morphologies (e.g., arrow) at this stage of development.
S. Matsumoto et al. / Developmental Biology 289 (2006) 372–383382subsequent generation of glia is virtually abolished. Also, unlike
Xenopus, NSCs in the mouse VZ are depleted at the expense of
precocious neuronal differentiation instead of being expanded
in the absence of Brg1. In addition, we find that the in vitro
differentiation of late gliogenic NSC into neurons is unaffected
by the loss of Brg1, but astrocyte differentiation is completely
blocked. The striking contrast between our findings in the
mouse compared to the previous studies in non-amniotic
vertebrates suggests extensive divergence in the role of
chromatin remodeling factors in mediating neural development.
The phenotype of the NC-Brg1Fl/FL mice and the cell culture
experiments suggest that Brg1 is a critical mediator of several
stages of mammalian neural development. We propose that
Brg1 suppresses neuronal differentiation in gliogenic NSCs
and mediates aspects of neuronal maturation after cells have
become committed to neuronal fates. It is clear that the early
generation of neurons, including the earliest born CR neurons,
occurs unperturbed in the brg1 mutant mice. Combined with
the observation that Brg1 expression does not appear in the VZ
until the onset of gliogenesis, our data suggest that Brg1 is not
required for the initial differentiation of neurons. Early stages
of neuronal maturation, however, do appear to be abnormal in
the brg1 knockouts, consistent with the observation that
neurons express Brg1 once that they have begun to differentiate
and migrate away from the VZ. The timing of calretinin
expression is premature in the mutant CR neurons and in a
subpopulation of cortical interneurons. Brg1 may, therefore,
play a critical role in defining neuronal subtype identities once
cells have become committed to neuronal differentiation.
One way that Brg1 may influence neuronal subtype
specification is through interactions with the RE1 silencing
transcription factor, REST. REST is a zinc finger protein that
binds to a conserved 23 bp motif called RE1 (Chong et al., 1995;
Schoenherr and Anderson, 1995). As NSCs differentiate into
neurons, REST and its co-repressors dissociate from RE1 sites,
allowing for the transcription of neuron-specific genes. In some
genes, however, transcription is regulated through interactions
with methylated DNA sequences that are distinct from RE1
(Ballas et al., 2005). SWI/SNF complexes that contain Brg1 can
interact with REST repressor complexes, and antibodies against
Brg1 can relieve the repression of RE1 reporter genes
(Battaglioli et al., 2002). Furthermore, recent evidence indicates
that Brg1 can influence the transcription of some genes by
altering DNA methylation (Banine et al., 2005). It is possible,
therefore, that, as Brg1 becomes expressed in gliogenic NSCs, it
interacts with REST complexes to prevent neuronal differenti-
ation. It may also, however, interact with similar complexes in
differentiating neurons to define neuronal subtypes.
It is unclear if Brg1 is also required for glial cell
differentiation. Our data suggest that, in the absence of Brg1,
gliogenic NSCs either become neurons or radial glia. One
possible way that Brg1 could regulate gliogenesis is through
interactions with the nuclear receptor co-repressor, N-CoR,
which actively represses astrocyte differentiation (Hermanson
et al., 2002). Brg1 and other SWI/SNF proteins interact with N-
CoR (Underhill et al., 2000), suggesting that the loss of Brg1
could alter N-CoR function in cells that would normallydifferentiate into astrocytes. It is unclear, however, whether
Brg1 inhibits or promotes N-CoR-mediated transcriptional
repression. Nonetheless, our results have significant implica-
tions for understanding how NSC fates are regulated at
different times during mammalian embryonic development
and may provide clues about how NSC differentiation can be
manipulated in a variety of pathological conditions.
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